EGFR signaling, which involves the mTOR pathway, is expressed in these tumors, and it is associated with tumor proliferation, invasive behavior, lower total resection, and epithelial-to-mesenchymal transition [60,61,62]; this latter is also mediated by the ADAM12 metalloprotease [62]. The gene discussed is EGFR; the disease is neoplasm.